Amiodarone - CAS 1951-25-3
Catalog number: 1951-25-3
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H29I2NO3
Molecular Weight:
645.32
COA:
Inquire
Targets:
Potassium Channel
Description:
Amiodarone, an iodine-rich benzofuran derivative, as a vaughan-Williams Class III antiarrhythmic agent it is an ATP-sensitive potassium channel inhibitor (IC50= 19.1 μM).
Purity:
≥99%
Appearance:
White photosensitive solid
Synonyms:
(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone Alphapharm Brand of Amiodarone Hydrochloride Amiobeta Amiodarex Amiodarona Amiodarone Amiodarone Hydrochloride Amiohexal Aratac Armstrong Brand of Amiodarone Hydrochloride
Solubility:
Soluble in DMSO
Storage:
Store in a cool and dry place and at 0 - 4℃ for short term (days to weeks) or -22℃ for long term (months to years).
MSDS:
Inquire
Shelf Life:
2 years
Boiling Point:
635.1±55.0 °C | Condition: Press: 760 Torr
Density:
1.580±0.06 g/cm3
InChIKey:
IYIKLHRQXLHMJQ-UHFFFAOYSA-N
InChI:
1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3
Canonical SMILES:
CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
1.[Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population].
Li CB1, Dai DP2, Hu GX, Pu CW, Cao YP, Cai JP. Zhonghua Yi Xue Za Zhi. 2016 Mar 15;96(10):776-80. doi: 10.3760/cma.j.issn.0376-2491.2016.10.006.
OBJECTIVE: To develop and evaluate a warfarin-dosing algorithm method which can be used to guide the adjustment of warfarin maintenance dose in Chinese Han population.
2.Rational design, synthesis and 2D-QSAR study of novel vasorelaxant active benzofuran-pyridine hybrids.
Srour AM1, Abd El-Karim SS2, Saleh DO3, El-Eraky WI3, Nofal ZM2. Bioorg Med Chem Lett. 2016 Mar 15. pii: S0960-894X(16)30274-8. doi: 10.1016/j.bmcl.2016.03.054. [Epub ahead of print]
Reaction of 3-aryl-1-(benzofuran-2-yl)-2-propen-1-ones 3a-c with malononitrile in the presence of sufficient amount of sodium alkoxide in the corresponding alcohol proceeds in a regioselective manner to afford 2-alkoxy-4-aryl-6-(benzofuran-2-yl)-3-pyridinecarbonitriles 4-37, which also obtained by treating ylidenemalononitriles 6a-q with 2-acetylbenzofuran 1 in the presence of sufficient amount of sodium alkoxide in the corresponding alcohol. The new chemical entities showed significant vasodilation properties using isolated thoracic aortic rings of rats pre-contracted with norepinephrine hydrochloride standard technique. Compounds 11, 16, 21, 24 and 30 exhibited remarkable activity compared with amiodarone hydrochloride the reference standard used in the present study. CODESSA-Pro software was employing to obtain a statistically significant QSAR model describing the bioactivity of the newly synthesized analogs (N=31, n=5, R2=0.846, R2cvOO=0.
3.Prediction of Positive Food Effect: Bioavailability Enhancement of BCS Class II Drugs.
Raman S1, Polli JE2. Int J Pharm. 2016 Apr 8. pii: S0378-5173(16)30288-5. doi: 10.1016/j.ijpharm.2016.04.013. [Epub ahead of print]
High-throughput screening methods have increased the number of poorly water-soluble, highly permeable drug candidates. Many of these candidates have increased bioavailability when administered with food (i.e. exhibit a positive food effect). Food is known to impact drug bioavailability through a variety of mechanisms, including drug solubilization and prolonged gastric residence time. In vitro dissolution media that aim to mimic in vivo gastrointestinal (GI) conditions have been developed to lessen the need for fed human bioequivalence studies. The objective of this work was to develop an in vitro lipolysis model to predict positive food effect of three BCS Class II drugs (i.e. danazol, amiodarone and ivermectin) in previously developed lipolysis media. This in vitro lipolysis model was comparatively benchmarked against FeSSIF and FaSSIF media that were modified for an in vitro lipolysis approach, as FeSSIF and FaSSIF are widely used in in vitro dissolution studies.
4.ECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case-Control Study.
Chen CY1, Tsai J, Hsu TY, Lai WY, Chen WK, Muo CH, Kao CH. Medicine (Baltimore). 2016 Mar;95(13):e3204. doi: 10.1097/MD.0000000000003204.
Refractory cardiac arrhythmia, which has a poor response to defibrillation and antiarrhythmia medication, is a complicated problem for clinical physicians during resuscitation. Extracorporeal membrane oxygenation (ECMO) may be used to sustain life in this situation. ECMO is useful for cardiopulmonary resuscitation among patients suffering from cardiac arrest; the use of ECMO in this context is called E-cardiopulmonary resuscitation. However, a large-scale and nationwide survey of ECMO usage in cases involving refractory cardiac arrhythmia during resuscitation is lacking. We aimed to clarify the characteristics and efficacy of the application of ECMO in cases involving refractory cardiac arrhythmia during resuscitation by conducting a nationwide study.Using national insurance data from 1996 to 2011, 2702 patients who received defibrillation and amiodarone injections were selected. We excluded trauma patients (n = 316) and those aged<20 years (n = 24).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Potassium Channel Products


CAS 910044-56-3 Tertiapin-Q

Tertiapin-Q
(CAS: 910044-56-3)

Tertiapin-Q, a derivative of the bee venom toxin tertiapin, is a high affinity blocker of inward-rectifier K+ channels. Tertiapin-Q binds to ROMK1 (Kir1.1) and ...

CAS 64190-70-1 Phe-Met-Arg-Phe, amide

Phe-Met-Arg-Phe, amide
(CAS: 64190-70-1)

Phe-Met-Arg-Phe, amide, also called as FMRF-NH2, belongs to Molluscan Cardioexcitatory Neuropeptide and dose dependently (ED50=23 nM) activates a K+current in t...

CAS 7081-53-0 Doxapram HCl

Doxapram HCl
(CAS: 7081-53-0)

Doxapram HCl inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.

CAS 199934-16-2 UCL 1684

UCL 1684
(CAS: 199934-16-2)

UCL 1684 is a potent and nonpeptidic blocker of the apamin-sensitive Ca2+-activated K+ channel (KCa2.1) (IC50 = 3 nM in rat sympathetic neurons). UCL 1684 was s...

CAS 524962-01-4 BeKm 1

BeKm 1
(CAS: 524962-01-4)

BeKm 1 is a potent and selective KV11.1 (hERG) channel blocker.

CAS 26944-48-9 Glibornuride

Glibornuride
(CAS: 26944-48-9)

Glibornuride is an anti-diabetic drug from the group of sulfonylureas. It has been shown to antagonize the relaxant response to the K+ channel opener cromakalim...

CAS 197525-99-8 TRAM 39

TRAM 39
(CAS: 197525-99-8)

TRAM 39 is a potent intermediate conductance Ca2+-activated K+ channel (KCa3.1) blocker (Kd = 60 nM) with no effect on cytochrome p450 activity. TRAM 39 has bee...

CAS 56995-20-1 Flupirtine

Flupirtine
(CAS: 56995-20-1)

Flupirtine is a selective neuronal potassium channel opener act as an Analgesic, having substituted pyridine with central analgesic properties.

CAS 202821-81-6 BMS 191011

BMS 191011
(CAS: 202821-81-6)

BMS 191011 is a potent opener of the large-conductance, Ca2+-activated potassium (maxi-K) channel. It is neuroprotectant in two distinct animal models of stroke...

CAS 18200-13-0 BL 1249

BL 1249
(CAS: 18200-13-0)

BL 1249 is a putative potassium channel activator and acts as a K2P2.1 (TREK-1) channel opener. It exhibits selectivity for bladder over vascular tissue in vitr...

ML252
(CAS: 1392494-64-2)

ML252 is a selective and brain penetrant KCNQ2 inhibitor (Kv7.2; IC50 value 69 nM) used in vivo to study KCNQ2 pharmocology.

Endoxifen HCl
(CAS: 1032008-74-4)

Endoxifen HCl, the active metabolite of Tamoxifen, ia a potent and selective estrogen receptor antagonist. Phase 2. Endoxifen shows anti-estrogenic effects, and...

CAS 279215-43-9 Tifenazoxide

Tifenazoxide
(CAS: 279215-43-9)

Tifenazoxide is a potent selective KATP channels opener with preference for Kir6.2/SUR1. Studies show that it inhibits glucose stimulated insulin release in vit...

AAQ chloride

AAQ chloride is a photoswitchable Kv channel blocker (IC50 = 2 and 64 μM at 500 nm and 380 nm, respectively) that switches conformation from cis to trans at 500...

CAS 113559-13-0 E-4031

E-4031
(CAS: 113559-13-0)

E-4031, a benzenesulfonamide derivative, could be used as a Class III antiarrhythmic agent due to its effect of blocking the ERG potassium channels.

AVE 0118 hydrochloride

AVE 0118 hydrochloride is a potassium channel blocker that has the potential for the treatment of sleep apnea syndrome. AVE 0118 functions without apparent effe...

BDS I

BDS I is a reversible Kv3.4 potassium channel blocker (IC50 = 47 nM) and Nav1.7 channel agonist. BDS I potentiates TTX-sensitive sodium currents in rat small do...

CAS 60563-36-2 DCEBIO

DCEBIO
(CAS: 60563-36-2)

DCEBIO is a Ca2+ sensitive K+ channel (SKCa) agonist stimulating Cl- secretion via activation of hKCa3.1 (IK1) potassium channels and activation of an apical Cl...

CAS 50679-08-8 Terfenadine

Terfenadine
(CAS: 50679-08-8)

Terfenadine is a potent open-channel blocker of hERG (IC50=204 nM), formerly used for the treatment of allergic conditions.

CAS 327062-46-4 NS 19504

NS 19504
(CAS: 327062-46-4)

NS 19504 is an activator of large-conductance Ca2+-activated potassium channels. It has relaxing effects on bladder smooth muscle.

Chemical Structure

CAS 1951-25-3 Amiodarone

Quick Inquiry

Verification code

Featured Items